2021
DOI: 10.1002/humu.24170
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic and clinical utility of next‐generation sequencing in children born with multiple congenital anomalies in the China neonatal genomes project

Abstract: Multiple congenital anomalies (MCAs) at birth have emerged as an important cause of neonatal morbidity and mortality. This study aimed to investigate the genetic causes and characteristics of clinical outcomes in a large cohort of neonates with MCAs. Clinical exome sequencing/exome sequencing/genome sequencing were undertaken from December 1, 2016 to December 1, 2019 to detect single nucleotide variations (SNVs) and copy number variations (CNVs) simultaneously in individuals who met the inclusion criteria. A t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
14
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 22 publications
(14 citation statements)
references
References 31 publications
0
14
0
Order By: Relevance
“…39 Sequencing of individuals with multiple congenital anomalies, particularly those across body systems, has a high likelihood to yield a molecular diagnosis. 40,41 Together, these findings suggest that additional clinical and genetic evaluations of boys with hypospadias may identify subclinical birth defects and improve molecular diagnoses for boys with multiple congenital anomalies.…”
Section: Discussionmentioning
confidence: 94%
“…39 Sequencing of individuals with multiple congenital anomalies, particularly those across body systems, has a high likelihood to yield a molecular diagnosis. 40,41 Together, these findings suggest that additional clinical and genetic evaluations of boys with hypospadias may identify subclinical birth defects and improve molecular diagnoses for boys with multiple congenital anomalies.…”
Section: Discussionmentioning
confidence: 94%
“…DNA fragments were enriched for exome sequences using the IDT xGen Exome Research Panel v2 (Integrated DNA Technologies, Coralville, IA, USA). According to our previous reports, sequencing was performed on NovaSeq 6000 (Illumina, San Diego, USA) according to protocols ( 10 ). The data analysis followed the pipeline established by our team ( 11 ).…”
Section: Methodsmentioning
confidence: 99%
“…The pathogenicity of the variant was defined based on the American College of Medical Genetics and Genomics criteria ( 12 ). Detailed methods can be found in our previous studies ( 13 , 14 ).…”
Section: Methodsmentioning
confidence: 99%